Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 15INDUSTRY 5NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Breast Neoplasms 13Endometrial Neoplasms 2Carcinoma, Ductal, Breast 2Peritoneal Neoplasms 1Fallopian Tube Neoplasms 1Cystadenocarcinoma, Serous 1Carcinoma, Lobular 1Breast Neoplasms, Male 1Breast Neoplasm Female 1Breast Carcinoma In Situ 1Breast Cancer Invasive Nos 1Advanced, Persistent, or Recurrent Endometrial Cancer 1

Interventions

Paclitaxel 8Doxorubicin 7Cisplatin 7Radiotherapy 4Filgrastim 4Chemotherapy, Adjuvant 3Tamoxifen 2Radiotherapy, Intensity-Modulated 2Observation 2Medroxyprogesterone 2Letrozole 2Ifosfamide 2Gene Expression Profiling 2Carboplatin 2Amifostine 2ridaforolimus 1perifosine 1lenvatinib 1irofulven 1abemaciclib 1X-Rays 1Trabectedin 1Therapeutics 1Taxes 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy, Adjuvant 1Polymerase Chain Reaction 1Phantoms, Imaging 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Endometrial Neoplasms × Letrozole × Clear all
NCT04393285 2026-03-09

Abemaciclib and Letrozole to Treat Endometrial Cancer

GOG Foundation

Phase 2 Active not recruiting
53 enrolled
Gynecologic

Endometrial Neoplasms

NCT00004251 2020-04-06

Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer

Canadian Cancer Trials Group

Phase 2 Completed
33 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡